8-K: Dermata Therapeutics Stockholders Approve Increased Share Reserve and Reverse Stock Split at Annual Meeting

Dermata Therapeutics' stockholders approved an increase to the company's equity incentive plan and a reverse stock split at the 2024 Annual Meeting.

Summary

• Dermata Therapeutics held its 2024 Annual Meeting of Stockholders on May 7, 2024.
• Stockholders approved an amendment to the 2021 Omnibus Equity Incentive Plan, increasing the maximum share reserve to 1,198,951 shares.
• The amendment also includes an annual evergreen provision, increasing the share reserve by 5% each year from 2025 to 2031, subject to board discretion.
• A reverse stock split was approved, with a ratio ranging from 1:5 to 1:30, to be determined by the board.
• The appointment of Moss Adams LLP as the independent auditor for the fiscal year ending December 31, 2024, was ratified.
• Three Class III directors, Gerald T. Proehl, Wendell Wierenga, Ph.D., and Kathleen Scott, were elected to the board.

Sentiment

Score: 7

Explanation: The document reflects standard corporate actions, such as increasing share reserves and a reverse stock split, which are generally neutral to slightly positive. The approval of these measures indicates the company is taking steps to manage its capital structure and remain compliant with listing requirements.

Positives

• The increase in the share reserve provides the company with more flexibility for future equity-based compensation and fundraising.
• The annual evergreen provision ensures the company can continue to attract and retain talent.
• The reverse stock split may help the company meet listing requirements and improve its stock price.

Negatives

• The reverse stock split could be perceived negatively by some investors, potentially leading to a decrease in share price.
• The increased share reserve could dilute existing shareholders' ownership.

Risks

• The board has the discretion to reduce or eliminate the annual increase in the share reserve.
• The exact ratio of the reverse stock split is yet to be determined, creating uncertainty for investors.
• The reverse stock split may not achieve the desired effect of increasing the stock price.

Future Outlook

The company will implement the approved reverse stock split at a ratio to be determined by the board. The company will also continue to use the equity incentive plan to attract and retain talent.

Management Comments

• The Board desires to increase the number of shares of the common stock of the Company reserved for issuance under the Plan.
• The Board desires to amend certain language within the Plan relating to the automatic increase in the number of shares authorized under the Plan.

Industry Context

The approval of the increased share reserve and reverse stock split is a common practice for companies seeking to manage their capital structure and meet listing requirements. These actions are often taken by companies in the biotechnology sector to fund research and development and to maintain compliance with exchange listing rules.

Comparison to Industry Standards

• Many biotechnology companies use equity incentive plans to attract and retain talent, with share reserves often increasing over time.
• Reverse stock splits are a common mechanism for companies to regain compliance with minimum share price requirements on exchanges like Nasdaq.
• The specific ratio of the reverse stock split (1:5 to 1:30) is within the typical range seen in similar situations.
• Companies like Cassava Sciences and Ocugen have also recently undertaken reverse stock splits to maintain their Nasdaq listing.

Management Changes

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split and the potential dilution from the increased share reserve.
• Employees may benefit from the increased flexibility of the equity incentive plan.
• The company's listing status on Nasdaq may be improved by the reverse stock split.

Next Steps

• The company will determine the exact ratio for the reverse stock split.
• The company will implement the amended equity incentive plan.
• The company will continue to operate under the direction of the newly elected board members.

Key Dates

Keywords

equity incentive plan, reverse stock split, share reserve, annual meeting, directors, stockholders, Moss Adams LLP, corporate governance